Caffeine + L-Theanine Stack
Caffeine + L-theanine is a widely used "nootropic" stack combining a CNS stimulant (caffeine, typically 40-200 mg) with L-theanine, an amino acid from tea (typically 100-400 mg). Small, short-term human RCTs show modest improvements in attention-switching, accuracy on demanding cognitive tasks, and subjective alertness, with L-theanine appearing to blunt some of caffeine's jitteriness and blood-pressure rise. The main dangers come almost entirely from the caffeine component: anxiety, insomnia, palpitations/tachyarrhythmia, and, in massive overdose from pure caffeine powder or high-dose tablets (not beverages), seizures and fatal cardiac arrhythmia (lethal blood levels ~80-100 mg/L). L-theanine itself has a benign short-term safety profile in trials up to ~400 mg/day. This is not a hormonal or anabolic agent and has no established role in strength/physique enhancement. Long-term safety of the specific combination, and safety in people with cardiac disease, anxiety disorders, or pregnancy, is not well studied. Evidence is short-term and many efficacy trials are industry-sponsored.
Mechanism of action
Pharmacokinetics
Caffeine: ~2.5-5 h in healthy non-smoking adults, highly variable and CYP1A2-dependent; markedly prolonged in pregnancy, with oral contraceptive use, and liver disease. L-theanine: short, roughly 1 h (rapid oral absorption, peak ~30-50 min). Figures reflect established pharmacology; individual variability is large.
Caffeine subjective/cognitive effects ~3-6 h but sleep disruption can persist much longer if taken in the afternoon/evening; combination cognitive effects in RCTs measured at 20-90 min post-dose. L-theanine acute effects a few hours.
Oral (capsules, tablets, or tea/beverage).
Caffeine is metabolized hepatically, predominantly by CYP1A2 (to paraxanthine, theobromine, theophylline), then renally excreted; clearance reduced by CYP1A2 inhibitors, pregnancy, and liver impairment, increased by smoking. L-theanine is hydrolyzed to glutamate and ethylamine (partly renally) and renally excreted. PK context is provided for monitoring/washout and interaction awareness, not for evading any testing.
For monitoring and washout planning, not drug-test evasion.
Physiological & performance effects
- Small improvements in accuracy and speed on attention-switching tasks when caffeine and L-theanine are taken together (multiple short-term RCTs)
- Reduced susceptibility to distraction and improved sustained attention/inhibitory control in some studies
- Increased subjective alertness and reduced self-reported tiredness/mental fatigue
- L-theanine may reduce caffeine-induced arousal/jitteriness (a 'smoother' stimulation)
- Effects are modest, inconsistent across endpoints, and measured acutely (minutes to ~90 min); several trials were industry-funded
- L-theanine alone can promote subjective relaxation/calmness and, in one pediatric RCT, improved some objective sleep-quality measures
- Caffeine alone drives most of the alertness/vigilance benefit; the combination's advantage over caffeine alone is small and not always present
Adverse effects by system
Driven by caffeine: dose-dependent increases in heart rate and blood pressure, palpitations, and, at high/toxic doses, tachyarrhythmias. Combination RCTs at low doses (e.g., 40 mg caffeine + 97 mg L-theanine) monitored BP/HR without alarming acute changes, and L-theanine may partly attenuate stress-induced BP rise, but high caffeine intake and overdose cause serious arrhythmia (fatal cases documented).
No evidence of hepatotoxicity from either component at typical doses; no adequate human data suggesting liver injury from the combination. Caffeine clearance is reduced in liver disease (accumulation risk), which is a PK, not hepatotoxicity, concern.
Not a hormonal agent; no evidence of clinically meaningful HPTA/testosterone suppression. Caffeine can transiently raise cortisol and catecholamines acutely. No adequate human data on gonadal-axis effects of the stack.
Caffeine crosses the placenta; higher maternal caffeine/coffee intake is associated in observational data with early-pregnancy bleeding and concerns about fetal growth. No adequate human data on L-theanine in pregnancy. Not established as affecting fertility at typical doses.
Driven by caffeine: anxiety, nervousness, restlessness, irritability, insomnia; can precipitate/worsen panic and anxiety disorders and cause caffeine-use disorder with a withdrawal syndrome (headache, fatigue, low mood). L-theanine tends toward calming and may partly offset caffeine anxiety, but does not eliminate it. One RCT reported L-theanine alone increasing 'headache' ratings.
No established nephrotoxicity at typical doses. Caffeine has a mild acute diuretic effect. In massive caffeine overdose, renal effects occur as part of systemic toxicity. No adequate human data on renal harm from the combination.
No characteristic hematologic toxicity from either component; no adequate human data indicating hematologic harm from the combination.
No characteristic dermatologic toxicity; diaphoresis can occur with high caffeine doses. No adequate human data on skin effects of the combination.
HPTA suppression & recovery
Suppression: None established / not applicable
This stack is a stimulant + amino acid nootropic, not an androgen, SERM, or other hormonal agent, and there is no adequate human evidence that it suppresses the hypothalamic-pituitary-gonadal axis. No SERM-based recovery protocol is relevant or advised. Anyone concerned about hormonal or fertility effects, or who is combining this with actual hormonal agents, should consult an endocrinologist rather than self-managing; single-SERM recovery, if ever contemplated for a genuinely suppressive drug, is a clinician-directed decision.
Monitoring
Cadence: Assess tolerability, sleep, anxiety, and resting HR/BP in the first days-weeks; re-evaluate with any dose change or new symptoms. Seek prompt clinical evaluation for cardiac or neuropsychiatric warning signs.
- Palpitations, irregular/racing heartbeat, chest pain
- Severe anxiety, agitation, confusion
- Tremor, muscle twitching, or seizure
- Repeated vomiting (a red flag for caffeine toxicity)
- Insomnia or worsening mood/panic
- Signs of overdose after high intake: tachycardia, hypertension then instability, hyperthermia — call emergency services
Contraindications
- Cardiac arrhythmia, known structural/ischemic heart disease, or uncontrolled hypertension (caffeine risk)
- Anxiety disorders, panic disorder, or insomnia (caffeine can worsen these)
- Pregnancy and breastfeeding (caffeine crosses placenta/enters milk; observational harm signals; L-theanine unstudied)
- Children/adolescents outside supervised research settings
- Concurrent use of other stimulants or high dietary caffeine (additive toxicity)
- CYP1A2 inhibitors or conditions that slow caffeine clearance (e.g., some fluoroquinolones, fluvoxamine, oral contraceptives, liver disease)
- History of caffeine-use disorder or seizure disorder
- Use of pure/bulk caffeine powder or high-dose caffeine tablets (extreme overdose risk)
Interaction profile
- MajorWith an anabolic steroid: Additive cardiovascular strain
- MajorWith a stimulant: Additive cardiovascular strain
- ModerateWith a SARM: Additive cardiovascular strain
- MajorWith thyroid hormone: Additive cardiovascular strain
- ModerateWith a GLP-1 / incretin agonist: Additive cardiovascular strain
- ModerateWith a melanocortin agonist: Additive hypertension
- MajorWith a QT-prolonging drug: QT prolongation
- ContraindicatedWith DNP: Additive cardiovascular strain
Check a specific combination in the interaction checker.
Reducing harm & when to stop
- Keep total daily caffeine (from all sources: this stack plus coffee/tea/energy drinks/pre-workout) well within moderate limits; do not stack multiple stimulant products.
- Never use pure/bulk caffeine powder or high-dose caffeine tablets — small measuring errors can be fatal; deaths in the literature came from tablets/powder, not beverages.
- Avoid afternoon/evening dosing to protect sleep; caffeine's effects and half-life vary widely between people.
- Start low to assess individual sensitivity; L-theanine does not neutralize caffeine toxicity — it only modestly blunts jitteriness.
- Stop and seek urgent medical care for chest pain, palpitations/irregular heartbeat, fainting, seizure, repeated vomiting, severe agitation, or confusion.
- Reduce or avoid if you develop anxiety, panic, insomnia, or dependence; taper caffeine to limit withdrawal headaches/fatigue.
- Avoid in pregnancy/breastfeeding and discuss any use with a clinician if you have heart disease, arrhythmia, hypertension, anxiety disorder, seizure history, or take interacting drugs (e.g., fluvoxamine, certain fluoroquinolones, oral contraceptives).
- This is not a performance/physique-enhancing drug; do not treat 'more' as better — higher caffeine doses increase risk without proportional benefit.
- Discuss with a clinician or pharmacist before combining with other medications or supplements, and get blood pressure checked if using regularly.
Citations (15)
Every clinical claim above is tied to a primary source. Overall evidence grade B — graded to the best available evidence for its core claims.
- 01
50 mg caffeine + 100 mg L-theanine improved speed/accuracy of attention-switching and reduced distractibility vs placebo in healthy adults (RCT).
- 02
97 mg L-theanine + 40 mg caffeine improved task-switching accuracy and self-reported alertness and reduced tiredness; BP and HR were measured (RCT).
- 03
L-theanine (250 mg) + caffeine (150 mg) improved attention/RVIP accuracy and reduced mental fatigue; L-theanine alone increased 'headache' ratings (RCT).
- 04
L-theanine (97 mg) + caffeine (40 mg) improved task-switching attention but not intersensory attention or subjective alertness (RCT).
- 05
Combined L-theanine + caffeine lowered tonic alpha-band EEG power and improved attention-task target discriminability (controlled trial).
- 06
In boys with ADHD, the L-theanine-caffeine combination improved overall cognition and Go/NoGo performance, while caffeine alone worsened inhibitory control (crossover RCT).
- 07
Review evidence that caffeine and L-theanine combined particularly improve attention-switching and alertness, and that L-theanine reduces caffeine-induced arousal.
ReviewPMID 28056735 ↗
- 08
Review: L-theanine may interact with caffeine to enhance attention-switching and the ability to ignore distraction, and may modulate caffeine's acute effects.
ReviewPMID 18254874 ↗
- 09
L-theanine attenuated stress-induced blood-pressure increases in high-stress-responders and reduced tension/anxiety; caffeine showed a smaller similar effect (RCT).
- 10
Caffeine seizures and cardiac arrhythmias occur at plasma ~15 mg/L or higher; concentrations of ~80-100 mg/L are considered lethal (systematic review of caffeine-related deaths).
ReviewPMID 34927622 ↗
- 11
Acute high-concentration caffeine intoxication caused fatal cardiac arrhythmia with beta-1 adrenoceptor-mediated myocardial injury (case report).
Case reportPMID 32918170 ↗
- 12
Fatal caffeine intoxication case series: average postmortem caffeine ~140 mg/L, deaths from high-dose tablets/powder not from caffeinated foods; ~80 mg/L considered lethal.
Case seriesPMID 24502704 ↗
- 13
L-theanine 400 mg/day for 6 weeks was well tolerated with no significant adverse events in an RCT (boys with ADHD).
- 14
L-theanine 400 mg/day (with pregnenolone) as antipsychotic augmentation over 8 weeks was well tolerated in an RCT.
- 15
Higher pre-pregnancy/pregnancy coffee (caffeine) intake was independently associated with increased risk of early-pregnancy bleeding; caffeine crosses the placenta and affects fetal growth (observational).
CohortPMID 32085746 ↗
Last reviewed 2026-07-06 · Verified against PubMed · Educational, not medical advice